MENU
+Compare
XLV
ETF ticker: NYSE ARCA
AS OF
Jan 24, 02:11 PM (EDT)
Price
$144.44
Change
+$0.35 (+0.24%)
Net Assets
37.92B

XLV stock forecast, quote, news & analysis

Category: @Health
XLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for XLV with price predictions
Jan 08, 2025

XLV in +1.01% Uptrend, growing for three consecutive days on January 08, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where XLV advanced for three days, in of 337 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on XLV as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for XLV just turned positive on December 27, 2024. Looking at past instances where XLV's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XLV declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for XLV entered a downward trend on December 31, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV).

Industry description

The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Market Cap

The average market capitalization across the The Health Care Select Sector SPDR® ETF ETF is 88.92B. The market cap for tickers in the group ranges from 9.7B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is HSIC at 9.7B.

High and low price notable news

The average weekly price growth across all stocks in the The Health Care Select Sector SPDR® ETF ETF was 24%. For the same ETF, the average monthly price growth was 24%, and the average quarterly price growth was 43%. MRNA experienced the highest price growth at 26%, while MRK experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the The Health Care Select Sector SPDR® ETF ETF was 9%. For the same stocks of the ETF, the average monthly volume growth was 156% and the average quarterly volume growth was -15%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 57
Price Growth Rating: 45
SMR Rating: 61
Profit Risk Rating: 56
Seasonality Score: -10 (-100 ... +100)
View a ticker or compare two or three
XLV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
One Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com